161 related articles for article (PubMed ID: 18543610)
1. CCR5-Delta32 polymorphism and susceptibility to cervical cancer: association with early stage of cervical cancer.
Singh H; Sachan R; Jain M; Mittal B
Oncol Res; 2008; 17(2):87-91. PubMed ID: 18543610
[TBL] [Abstract][Full Text] [Related]
2. CCR5 Delta32 polymorphism: associated with gallbladder cancer susceptibility.
Srivastava A; Pandey SN; Choudhuri G; Mittal B
Scand J Immunol; 2008 May; 67(5):516-22. PubMed ID: 18405329
[TBL] [Abstract][Full Text] [Related]
3. Chemokine receptor 5 (CCR5) deletion polymorphism in North Indian patients with coronary artery disease.
Sharda S; Gilmour A; Harris V; Singh VP; Sinha N; Tewari S; Ramesh V; Agrawal S; Mastana S
Int J Cardiol; 2008 Feb; 124(2):254-8. PubMed ID: 17383752
[TBL] [Abstract][Full Text] [Related]
4. Association between chemokine receptor 5 delta32 polymorphism and susceptibility to cancer: a meta-analysis.
Lee YH; Song GG
J Recept Signal Transduct Res; 2015; 35(6):509-15. PubMed ID: 25203595
[TBL] [Abstract][Full Text] [Related]
5. CCR5 genetic variants and epidemiological determinants for HPV infection and cervical premalignant lesions.
Mangieri LFL; Sena MM; Cezar-Dos-Santos F; Trugilo KP; Okuyama NCM; Pereira ÉR; Maria GCQ; Watanabe MAE; de Oliveira KB
Int J Immunogenet; 2019 Oct; 46(5):331-338. PubMed ID: 31183980
[TBL] [Abstract][Full Text] [Related]
6. The role of chemokine and chemokine receptor gene variants on the susceptibility and clinicopathological characteristics of bladder cancer.
Kucukgergin C; Isman FK; Dasdemir S; Cakmakoglu B; Sanli O; Gokkusu C; Seckin S
Gene; 2012 Dec; 511(1):7-11. PubMed ID: 22982413
[TBL] [Abstract][Full Text] [Related]
7. Genetic polymorphism of chemokine receptors CCR2 and CCR5 in Swedish cervical cancer patients.
Zheng B; Wiklund F; Gharizadeh B; Sadat M; Gambelunghe G; Hallmans G; Dillner J; Wallin KL; Ghaderi M
Anticancer Res; 2006; 26(5B):3669-74. PubMed ID: 17094383
[TBL] [Abstract][Full Text] [Related]
8. The role of the CCR5 Delta32 polymorphism in abdominal aortic aneurysms.
Sandford B; Bown M; London N; Sayers R
Int J Immunogenet; 2009 Aug; 36(4):199-205. PubMed ID: 19476483
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of the chemokine receptor CCR5-Delta32 gene mutation in periodontal disease.
Folwaczny M; Glas J; Török HP; Fricke K; Folwaczny C
Clin Immunol; 2003 Dec; 109(3):325-9. PubMed ID: 14697747
[TBL] [Abstract][Full Text] [Related]
10. Lack of association between chemokine receptor 5 (CCR5) δ32 mutation and pathogenesis of asthma in Iranian patients.
Abousaidi H; Vazirinejad R; Arababadi MK; Rafatpanah H; Pourfathollah AA; Derakhshan R; Daneshmandi S; Hassanshahi G
South Med J; 2011 Jun; 104(6):422-5. PubMed ID: 21886032
[TBL] [Abstract][Full Text] [Related]
11. CC chemokine receptor 5 delta32 polymorphism in two independent cohorts of hepatitis C virus infected patients without hemophilia.
Wasmuth HE; Werth A; Mueller T; Berg T; Dietrich CG; Geier A; Schirin-Sokhan R; Gartung C; Lorenzen J; Matern S; Lammert F
J Mol Med (Berl); 2004 Jan; 82(1):64-9. PubMed ID: 14673528
[TBL] [Abstract][Full Text] [Related]
12. Common CCR 5 polymorphism in stroke: the CCR 5 delta32 polymorphism differentiates cardioembolism from other aetiologies of ischaemic cerebrovascular diseases.
Kostulas N; Markaki I; Kostulas V; Hillert J; Kostulas K
Scand J Immunol; 2009 Nov; 70(5):475-80. PubMed ID: 19874552
[TBL] [Abstract][Full Text] [Related]
13. Association of chemokines receptor (CCR5 Delta32) in idiopathic recurrent miscarriages among north Indians.
Parveen F; Tripathi G; Singh B; Agrawal S
Arch Gynecol Obstet; 2009 Aug; 280(2):229-34. PubMed ID: 19116725
[TBL] [Abstract][Full Text] [Related]
14. CC chemokine receptor 5 Δ32 polymorphism: association analysis and allele distribution among cutaneous leishmaniasis patients from Pakistan.
Sophie M; Hameed A; Muneer A; Samdani AJ; Saleem S; Azhar A
J Cutan Pathol; 2016 Jul; 43(7):564-70. PubMed ID: 26970327
[TBL] [Abstract][Full Text] [Related]
15. Association of polymorphisms in MCP-1, CCR2, and CCR5 genes with the risk and clinicopathological characteristics of prostate cancer.
Kucukgergin C; Isman FK; Cakmakoglu B; Sanli O; Seckin S
DNA Cell Biol; 2012 Aug; 31(8):1418-24. PubMed ID: 22612293
[TBL] [Abstract][Full Text] [Related]
16. CCR5-Delta32 mutation is strongly associated with primary sclerosing cholangitis.
Eri R; Jonsson JR; Pandeya N; Purdie DM; Clouston AD; Martin N; Duffy D; Powell EE; Fawcett J; Florin TH; Radford-Smith GL
Genes Immun; 2004 Sep; 5(6):444-50. PubMed ID: 15215889
[TBL] [Abstract][Full Text] [Related]
17. Relationship between chemokine receptor 5 Δ32/W gene polymorphism and lupus nephritis.
Zhou TB; Jiang ZP; Zhou JF; Su N
Hum Immunol; 2014 Sep; 75(9):968-72. PubMed ID: 25167769
[TBL] [Abstract][Full Text] [Related]
18. Possible Impact of 190G > A CCR2 and Δ32 CCR5 Mutations on Decrease of the HBV Vaccine Immunogenicity-A Preliminary Report.
Ganczak M; Skonieczna-Żydecka K; Drozd-Dąbrowska M; Adler G
Int J Environ Res Public Health; 2017 Feb; 14(2):. PubMed ID: 28208753
[No Abstract] [Full Text] [Related]
19. CCR5-Δ32 polymorphism is a genetic risk factor associated with dyslipidemia in patients with type 1 diabetes.
Słomiński B; Ławrynowicz U; Ryba-Stanisławowska M; Skrzypkowska M; Myśliwska J; Myśliwiec M
Cytokine; 2019 Feb; 114():81-85. PubMed ID: 30420202
[TBL] [Abstract][Full Text] [Related]
20. Association between the chemokine receptor 5 delta32 polymorphism and rheumatoid arthritis: a meta-analysis.
Lee YH; Bae SC; Song GG
Mod Rheumatol; 2013 Mar; 23(2):304-10. PubMed ID: 22638733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
